Role of IL28-B Polymorphism (rs12979860) on Sustained Virological Response to Pegylated Interferon/Ribavirin in Iranian Patients With Chronic Hepatitis C

BACKGROUND: The current medical treatment for hepatitis C virus (HCV) infection is pegylated interferon plus ribavirin, but just 50% of genotype 1 HCV patients and about 80% of HCV genotype 3 patients are treated completely. Recently, the rs12979860 C/T polymorphism, which is located 3 kb upstream o...

Descripción completa

Detalles Bibliográficos
Autores principales: Daneshvar, Mahtab, Nikbin, Mehri, Talebi, Solmaz, Javadi, Foozieh, Aghasadeghi, Mohammad Reza, Mahmazi, Sanaz, Sadat, Seyed Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253204/
https://www.ncbi.nlm.nih.gov/pubmed/28144454
http://dx.doi.org/10.5812/ircmj.28566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253204/
https://www.ncbi.nlm.nih.gov/pubmed/28144454
http://dx.doi.org/10.5812/ircmj.28566

Ejemplares similares